Survival of gastric cancer patients based on pathologic and demographic characteristics in Mazandaran between 2007 and 2013
- PMID: 31749920
- PMCID: PMC6820842
Survival of gastric cancer patients based on pathologic and demographic characteristics in Mazandaran between 2007 and 2013
Abstract
Aim: Survey of the survival levels of gastric cancer and its effective causes.
Background: The survival of gastric cancer because of the advances in this type of cancer cures has been increased during the last decades.
Methods: 643 patients evolved by gastric cancer referred to Imam Khomeini hospital of Sari (2007- 2013) were studied. According to this method, the numbers of 74 patients were neglected because of defective data, and the number of 569 patients went under study. The level of survival was determined by use of Kaplan Meier, so to determine the causes affecting on the patients' survival, the univariate analysis of Log-rank test was used.
Results: Regarding the follow up of these patients during 2013 Nov-Dec the one, 2, 3, 4 and 5 years of survival of these patients were estimated equal to 0.77, 0.65, 0.52, 0.44, 0.27 percent and the survival median equal to 19 months, so survival means equal to 24.49 months. Based on the ranked logarithm test and FDR method some variables like stage (p<0.001) Radiotherapy (p<0.005) and undergo Surgery before Adjuvant chemotherapy (p<0.001) were determined as the effective factors on the survival probability.
Conclusion: The life length of the patients under this article in comparison with developed countries is shallow that might be because of late reference or delayed diagnosis and the shortness of cure facilities. In this way, some materials like soon diagnosis and screen methods could be effective on the increase in patients' survival.
Keywords: Gastric cancer; Kaplan Meier estimate; Survival analysis.
©2019 RIGLD, Research Institute for Gastroenterology and Liver Diseases.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Survival prediction of gastric cancer patients by Artificial Neural Network model.Gastroenterol Hepatol Bed Bench. 2018 Spring;11(2):110-117. Gastroenterol Hepatol Bed Bench. 2018. PMID: 29910851 Free PMC article.
-
Factors associated with early recurrence after curative surgery for gastric cancer.World J Gastroenterol. 2015 May 21;21(19):5934-40. doi: 10.3748/wjg.v21.i19.5934. World J Gastroenterol. 2015. PMID: 26019458 Free PMC article.
-
Survival in gastric cancer patients: univariate and multivariate analysis.East Afr J Public Health. 2009 Apr;6 Suppl(1):41-4. doi: 10.4314/eajph.v6i3.45773. East Afr J Public Health. 2009. PMID: 20084985
-
Concurrent chemoradiotherapy in adjuvant treatment of breast cancer.Radiat Oncol. 2009 Apr 7;4:12. doi: 10.1186/1748-717X-4-12. Radiat Oncol. 2009. PMID: 19351405 Free PMC article.
-
Factors Affecting the Survival of Patients with Gastric Cancer Undergone Surgery at Iran Cancer Institute: Univariate and Multivariate Analyses.Iran J Public Health. 2014 Jun;43(6):800-8. Iran J Public Health. 2014. PMID: 26110151 Free PMC article.
Cited by
-
Survival of gastric cancer patients in Iran: a systematic review and meta-analysis.Gastroenterol Hepatol Bed Bench. 2023;16(3):245-258. doi: 10.22037/ghfbb.v16i2.2674. Gastroenterol Hepatol Bed Bench. 2023. PMID: 37767325 Free PMC article. Review.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Cancer J Clin. 2005;55:74–108. - PubMed
-
- Nazir S, Hussain T, Ayub A, Rashid U, MacRobert AJ. Nanomaterials in combating cancer: therapeutic applications and developments. Nanomedicine. 2014;10:19–34. - PubMed
-
- Fock K. The epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40:250–60. - PubMed
-
- Biglarian A, Hajizadeh E, Kazemnejad A, Zali M. Survival analysis of gastric cancer patients using Cox model&58; a five year study. Tehran Univers Med J. 2009;67:317–25.
-
- Prabhu V, Uzzaman S, Grace VMB, Guruvayoorappan C. Nanoparticles in drug delivery and cancer therapy: the giant rats tail. J Cancer Ther. 2011;2:325–34.
LinkOut - more resources
Full Text Sources
Research Materials